Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 revision on the page. This appears to be a minor version update with no substantive changes to study content.
    Difference
    0.1%
    Check dated 2026-01-14T03:48:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer updates remove 'HHS Vulnerability Disclosure' and add a revision label 'Revision: v3.3.3'. The study content and status remain unchanged.
    Difference
    0.1%
    Check dated 2025-12-23T22:29:22.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not all relate to the study, and updated the page revision to v3.3.2. The corresponding deletions reference PubMed-derived publications and list revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:15:50.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removed the government funding status banner that warned about potential data delays and directed users to opm.gov for updates.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:29.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    UI/layout updates were applied to the Study Details page with no substantial changes to core study information such as eligibility, enrollment, endpoints, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:05:13.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T05:30:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.